Orit Shaked

Orit Shaked serves as a Commercial and Strategy Consultant at Scala Biodesign since October 2023, contributing to the development of innovative computational solutions for protein commercialization. Shaked's experience extends to key roles in organizations such as Immunai and Quris, focusing on commercial and sales strategy and serving as the Chief Business Officer, respectively. As a member of 8400 - The Health Network and a former strategic partnerships lead at Yeda R&D, Shaked has demonstrated expertise in fostering collaborations. Previous positions include Head of Commercial Operations at CytoReason and CEO at BioRap Technologies LTD, highlighting a strong background in healthcare AI and technology transfer. Shaked's academic credentials include an MBA and a PhD from the Technion - Israel Institute of Technology, alongside executive education programs at esteemed institutions like Harvard Business School and the University of California, Irvine.